Search Results

) that cause nephrogenic diabetes insipidus "Loss-of-function mutations of the arginine vasopressin receptor AVPR2 is a kind of G protein coupled receptor (GPCR) and mainly couples with Gαs protein leading to cAMP Investigation into the characterization of biased receptors may give insights into the relationship between the conformational change of the receptor because of the mutation and related downstream signaling. R68W showed bias to coupling with Gαq/11 protein rather than V162A and wild-type receptor.

The sixth transmembrane region of a pheromone G-protein coupled receptor, Map3, is implicated in discrimination Although such pheromone/receptor systems are likely to function in both mate choice and prezygotic isolation , very few studies have focused on the stringency of pheromone receptors. Next, we swapped individual domains of Mam2 and Map3 with the respective domains in SoMam2 and SoMap3 , which revealed differences between the receptors both in the intracellular regions that regulate the

August 2022 "The atypical chemokine receptor 1 (ACKR1) was discovered on erythrocytes as the Duffy blood group antigen ( Cutbush et al., 1950 ), also called Duffy-antigen/receptor for chemokines, or DARC (

why two drugs with similar affinity may behave completely differently , and how the secret lies in receptor In this session, you’ll gain: ✅ A deeper understanding of how every ligand alters receptor conformation—and Ligands don’t just “bind”—they change  the receptor. These changes can alter how the receptor talks to G proteins, arrestins, or other receptors. receptors, where ligand context fundamentally changes modulator behavior.

How the Mass Action Law underpins nearly every model Future of Receptor Theory: Linkage vs.

In particular, CBD is able to modulate different receptors in the endocannabinoid system, some of which belong to the family of G-protein-coupled receptors (GPCRs). 55 (GPR55) and the cannabinoid type 1 receptor (CB1). addition, our results suggest a previously unknown sodium-binding site located in the extracellular domain of the CB1 receptor.

Nanobody binding stabilizes G-protein-coupled receptors (GPCR) in a fully active state and modulates conformational changes induced by the binding of a nanobody (Nb80) on the active-like β2 adrenergic receptor proximity of transmembrane (TM) helices 5 and 7, and favors the fully active-like conformation of the receptor contrast to the conditions under which no intracellular binding partner is bound, in which case the receptor intracellular loop 2 and extracellular loop 2 are captured from the trajectories of various ligand-bound receptors

August 2022 A NanoBRET-Based H 3 R Conformational Biosensor to Study Real-Time H 3 Receptor Pharmacology Membranes and Living Cells "Conformational biosensors to monitor the activation state of G protein-coupled receptors addition to the molecular pharmacology assay toolbox to characterize ligand efficacy at the level of receptor We recently reported the initial characterization of a NanoBRET-based conformational histamine H3 receptor

Numerous physiological effects of melatonin are mediated via its specific G protein-coupled receptors (GPCRs) named the MT1 receptor, which couples to both Gq and Gi proteins, and the MT2 receptor, which We investigated whether melatonin receptors are expressed on airway smooth muscle; whether they regulate We detected the mRNA and protein expression of the melatonin MT2 but not the MT1 receptor in native human Activation of melatonin MT2 receptors with either pharmacological concentrations of melatonin (10-100

August 2022 G protein-coupled receptor kinase type 2 and β-arrestin2: Key players in immune cell functions and inflammation "G protein-coupled receptor kinase type 2 (GRK2) and β-arrestin2 are representative proteins that regulate the transduction and trafficking of G protein-coupled receptor (GPCR) signaling

conditions, what appears to be a second high-affinity site may simply reflect kinetic factors—such as ligand-receptor-G

proteomes, we identified lysosomal cholesterol signaling (LYCHOS, previously annotated as G protein-coupled receptor

2026 GPCR Pharmacology AMA: Receptor Theory, Biased Signaling & Assay Interpretation The first GPCR Pharmacology Kenakin will address receptor theory, assay interpretation, biased signaling, and practical drug discovery Short conceptual breakdowns Focused receptor theory discussions Clear explanations reinforcing disciplined What seems definitive during early screening can shift as assay systems, receptor expression levels, scientific discussion A continually expanding on-demand archive Sustained exposure to quantitative receptor

Obesity-induced changes in human islet G protein-coupled receptor expression: Implications for metabolic regulation G protein-coupled receptors (GPCRs) are a large family of cell surface receptors that are

Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment G protein-coupled receptors (GPCRs) are cell surface receptors that mediate the function of a great variety

September 2022 Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify receptor-transducer coupling and mediate intracellular pathway bias "Within the intestine, the human G protein-coupled receptor activation and signaling of 10 different heterotrimeric G proteins, ligand-induced arrestin recruitment, and receptor results reveal that the extended N-terminus of the long isoform limits G protein activation yet elevates receptor-β-arrestin contributed by the extended N-terminus of the long GPR35 isoform limits the extent of agonist-induced receptor-β-arrestin2

Odorant G protein-coupled receptors as potential therapeutic targets for adult diffuse gliomas: a systematic analysis and review Odorant receptors (ORs) account for about 60% of all human G protein-coupled receptors

G protein-coupled receptor kinase 2 is essential to enable vasoconstrictor-mediated arterial smooth muscle circulation of vasoconstrictors, resulting in enhanced signalling through their cognate G protein-coupled receptors In VSMC, G protein-coupled receptor kinase 2 (GRK2) is known to regulate numerous vasoconstrictor GPCRs

The mouse cytomegalovirus G protein-coupled receptor homolog, M33, coordinates key features of in vivo repertoire Common to all cytomegalovirus (CMV) genomes analysed to date is the presence of G protein-coupled receptors IMPORTANCE G protein-coupled receptors (GPCRs) act as cell surface molecular "switches" which regulate

Breakthroughs this week: 12th Adhesion GPCR Workshop (Düsseldorf, Sept 16–18, 2026); Free fatty acid receptor These sessions span foundational pharmacology, receptor biology, modeling, translational strategy, and From dopamine D1 receptor desensitization and GRK isoform specificity to lipid raft biology, the discussion highlights how membrane context reshapes receptor behavior. Bitter taste receptors extend beyond taste biology.

Phenylalanine 193 in Extracellular Loop 2 of the β 2-Adrenergic Receptor Coordinates β-Arrestin Interaction G protein-coupled receptors (GPCRs) transduce a diverse variety of extracellular stimuli into intracellular These receptors are the most clinically productive drug targets at present. components of receptor-effector interactions remain incompletely described. SIGNIFICANCE STATEMENT: The role of extracellular G protein-coupled receptor (GPCR) domains in mediating

Reflex arcs, compensatory pathways, and receptor trafficking can turn your expected outcome on its head red flags early and make course corrections before trials derail. ✅ Practical strategies  for using receptor Dobutamine’s dual action on beta and alpha receptors, for example, invites reflex bradycardia that blunts Internalized Signaling: Same Receptor, Different Story A GPCR response isn’t always over when the receptor In this module, you’ll explore how some receptor–agonist complexes continue signaling from endosomes,

, essential to maintaining proper cardiac output and circulation, is regulated by G protein-coupled receptor

Watch Episode 172 What happens when the career you planned no longer feels right? For Catherine Demery, it meant rewriting everything on her own terms. She entered undergrad set on becoming a pharmacist. After excelling in the PCAT and gaining admission to pharmacy school at the University of Michigan, it seemed like her path was locked in. But something shifted. “I kind of had an identity crisis because I think I realized in that moment that I didn't want to be a pharmacist but I had tailored four years of my life to doing so." Two weeks before orientation, Catherine deferred her acceptance. It was a bold, uncertain move—but one that became the catalyst for a new trajectory. She found herself drawn toward the science behind the drugs, rather than their clinical application. That insight eventually led her into industry. Learning the Lab, Learning Herself During her time at the contract research organization (CRO) in Ann Arbor, Catherine was immersed in analytical work under stringent GLP/GMP standards. It was here that the disciplined structure of industry science helped her re-find purpose and build confidence for what came next. “This wasn’t with much foresight for a couple years down the road. It was mostly just because, I need to be back in the lab.” In that environment, every project brought new challenges—deadlines, documentation, and deliverables for paying clients. Catherine’s methodical retention of those skills later gave her a solid foundation in her academic work, even when expectations were looser in academia. The Spark of Addiction Science After two years in industry, Catherine enrolled in a master’s program in pharmacogenomics at Manchester University. There, she chose to write a review on genetic variation in susceptibility to alcoholism and opioid addiction—a decision that would reshape her academic ambitions. “...I had a light bulb moment where I felt for the first time in my life, I understood why people pursued a PhD. I was staying up super late. I was excited to work on this, till 2 or 3 a.m.” That project was her lightbulb moment. She finally understood what it meant to be driven by a research question, not just assigned to one. For the first time, she saw herself as a future researcher, not just a technician or a student. A Detour Through Immunology Her growing interest in addiction led her to the NIH’s Perinatology Research Branch in Detroit. While her work there focused on immunological changes in pregnancy—not addiction—it was a valuable chapter. She gained exposure to in vivo models, immunology, and complex study design, while also getting closer to patient-centered research. “It really forced me to kind of patch up all my immunology holes and then apply them. I came away from that job with just a whole new appreciation for immunology and for pregnancy. It was really, really fascinating… and just eye opening to a part of the world that I don’t think I would have put that much thought into ever again.” This experience sharpened her conceptual range and prepared her for the next step. Returning to the Opioid Questions That Mattered Now, as a PhD candidate in the Traynor and Anand labs at the University of Michigan, Catherine is focused on the mechanisms of opioid-induced respiratory depression, particularly involving fentanyl and xylazine. Her current work examines how these substances, when used alone or together, impair breathing in mice. She uses whole-body plethysmography and pulse oximetry to dissect the specific ways these drugs impact the respiratory cycle. It’s rigorous pharmacology, but deeply tied to urgent public health needs. And it’s also deeply personal. "I've always been really passionate and somewhat sensitive to people who struggle with opioid abuse. I had a few friends who became addicted and, really sadly, many of whom actually passed away as a result of an overdose. And so, that certainly shaped my interests and passions as a scientist." What Can You Learn from Catherine’s Story? A career pivot is not a failure—it’s a refined strategy. Industry can build skills that academia often overlooks. Your passion might not come first—it might come from doing the work. The most impactful science is often personal. Technical discipline is transferable—even across research cultures. The Importance of Passion in Research Catherine's journey highlights the importance of passion in research. It is not just about following a predetermined path; it is about discovering what truly drives you. Passion can lead to groundbreaking discoveries and a fulfilling career. When you find something that excites you, it can transform your work into a source of joy and motivation. Catherine's experience serves as a reminder that it is never too late to change direction and pursue what you love. Embracing Change and Uncertainty Change can be daunting, especially when it involves stepping away from a well-defined career path. However, embracing uncertainty can lead to unexpected opportunities. Catherine's decision to defer pharmacy school was a leap of faith that opened new doors. In life and career, taking risks can lead to personal and professional growth. It is essential to remain open to new experiences and to trust your instincts. This mindset can lead to a more fulfilling and successful career. Conclusion: A Journey of Self-Discovery Catherine Demery's story is one of self-discovery and resilience. It shows that career paths can evolve, and that it is possible to find fulfillment in unexpected places. Her journey illustrates the power of following one's passion and the importance of being adaptable in the face of change. In the end, it is about finding what resonates with you and pursuing it wholeheartedly. Catherine's experience serves as an inspiration for anyone considering a career change or seeking to align their work with their passions. _______ Keyword Cloud : #XylazineResearch #OpioidPharmacology #muOpioidReceptor #RespiratoryDepression #AddictionScience #DrGPCRecosystem #FentanylOverdose

on the mechanism of signal activation, ligand selectivity and allosteric modulation in angiotensin receptors Thus, we need to know much more about the structures of receptor-ligand complexes at high resolution. Recently, X-ray structures of both AngII receptors (AT1 and AT2 receptors) bound to peptide and non-peptide , as the basis of ligand selectivity, efficacy, and regulation of the molecular functions of the receptors This review covers the new data elucidating the structural dynamics of AngII receptors and how structural

GPCR, a nonprofit organization serving the global G protein-coupled receptor (GPCR) research community efforts are supported by characterization approaches that include knockout/knockdown testing, endogenous receptor

The activation is weaker than the receptor's natural peptide agonist suggests it should be. The receptor samples many states. The peptide does not pull the receptor into activation. domain, and influences the receptor's conformational equilibrium from there. decisions that determine receptor fate inside the cell.

2022 N-terminal alterations turn the gut hormone GLP-2 into an antagonist with gradual loss of GLP-2 receptor selectivity towards more GLP-1 receptor interaction "Background and purpose: To fully elucidate the regulatory role of the GLP-2 system in the gut and the bones, potent and selective GLP-2 receptor (GLP To examine selectivity, COS-7 cells expressing human GLP-1 or GIP receptors were assessed for cAMP accumulation

pro-inflammatory neutrophil response, signaling downstream of an agonist-activated G protein-coupled receptor Among the family of GPCR kinases (GRKs) that regulate receptor phosphorylation and signaling termination The medium chain fatty acid receptor GPR84 as well as formyl peptide receptor 2 (FPR2), receptors expressed

Previously, we identified potent positive crosstalk between insulin/IGF-1 receptors and G protein-coupled